Fumiaki Takahashi - Publications

Asymmetric urinary lesions associated with Proteus mirabilis infection in a beef calf.

Journal: Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc

Published: September 03, 2026

Birth weight Z-score and placental insufficiency as predictors of meconium-related ileus in preterm infants.

Journal: American journal of perinatology

Published: July 15, 2026

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2023 and Annual Treatment Report for 2018.

Journal: The journal of obstetrics and gynaecology research

Published: June 08, 2026

Clinical efficacy of anti-PD-1 immunotherapy with localized non-ablative irradiation against metastatic lymph node in patients with metastatic gastric cancer.

Journal: Clinical and translational radiation oncology

Published: March 09, 2026

Anatomical Predictors of Optimal Cryoballoon Size Selection: A Prospective Comparison of 28 mm Versus 31 mm Size-Adjustable Balloon Modes.

Journal: Journal of arrhythmia

Published: January 31, 2026

Benefits of PARP inhibitor rechallenge in patients with platinum-sensitive recurrent ovarian cancer previously treated with a PARP inhibitor: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: January 16, 2026

Plasma levels of antimicrobial peptide LL-37 as a biomarker of sleep quality in patients with obstructive sleep apnea: A clinical observational study.

Journal: PloS one

Published: January 02, 2026

Trends in the management and prognosis of mucinous borderline ovarian tumors: analysis of 12,766 cases from the JSOG Gynecologic Tumor Registry (2004-2018).

Journal: International journal of clinical oncology

Published: October 29, 2025

Survival and prognostic factors in vaginal cancer: an analysis of 2016-2020 nationwide data.

Journal: International journal of clinical oncology

Published: October 28, 2025

Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatment.

Journal: International journal of clinical oncology

Published: October 20, 2025

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2022 and Annual Treatment Report for 2017.

Journal: The journal of obstetrics and gynaecology research

Published: October 08, 2025

Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study.

Journal: Anticancer research

Published: September 20, 2025